Cargando…
Risk of Developing Melanoma With Systemic Agents Used to Treat Psoriasis: A Review of the Literature
BACKGROUND: Psoriasis is a chronic inflammatory skin disease induced by autoimmune-like dysregulation of the immune system. Treatment options have drastically evolved in recent years, and treatment advances that target specific cytokines and other molecules involved in dysregulation have had a profo...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750137/ https://www.ncbi.nlm.nih.gov/pubmed/34392725 http://dx.doi.org/10.1177/12034754211038509 |